|The [Arg8]-Vasopressin n/a (Catalog #MBS352002) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s [Arg8]-Vasopressin can be used in a range of immunoassay formats including, but not limited to, Histo. Researchers should empirically determine the suitability of the [Arg8]-Vasopressin n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
This pooled antibody was raised in rabbits which were immunized with synthetic Arg8-Vasopressin (AVP. ADH) covalently attached onto bovine thyroglobulin as a carrier protein. The pooled antibody has been shown to be specific for Arg8-Vasopressin and has been characterized by immunocytochemistry. ELISA. and RIA techniques. and is suitable for cell and tissue staining. for immunoprecipitation. and for passive immunization.
Dilute the lyophilized antibody with 0.10 ml of 10 mg/ml BSA in PBS for the equivalent of whole antiserum. or with additional buffer for more dilute antibody. The lyophilized powder should be stored at 4 degree C until rehydrated. then we recommend aliquoting the antibody into smaller portions and freezing the aliquots at -20 degree C. Do not subject this antibody to repeated freeze/thaw cycles.
Each vial contains 0.10 ml of "neat" antiserum.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing [Arg8]-Vasopressin are readily searchable from our website. Different antibodies against the same target such as [Arg8]-Vasopressin may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.